ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 原著論文

Prospective Multi-Institutional Study of Definitive Radiotherapy With High-Dose-Rate Intracavitary Brachytherapy in Patients With Nonbulky (<4-cm) Stage I and II Uterine Cervical Cancer (JAROG0401/JROSG04-2).

https://repo.qst.go.jp/records/46262
https://repo.qst.go.jp/records/46262
99238a41-e075-405b-88c4-2c058dc9bab4
Item type 学術雑誌論文 / Journal Article(1)
公開日 2012-02-06
タイトル
タイトル Prospective Multi-Institutional Study of Definitive Radiotherapy With High-Dose-Rate Intracavitary Brachytherapy in Patients With Nonbulky (<4-cm) Stage I and II Uterine Cervical Cancer (JAROG0401/JROSG04-2).
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Toita, Takafumi

× Toita, Takafumi

WEKO 460726

Toita, Takafumi

Search repository
Kato, Shingo

× Kato, Shingo

WEKO 460727

Kato, Shingo

Search repository
Niibe, Yuzuru

× Niibe, Yuzuru

WEKO 460728

Niibe, Yuzuru

Search repository
Ohno, Tatsuya

× Ohno, Tatsuya

WEKO 460729

Ohno, Tatsuya

Search repository
Kazumoto, Tomoko

× Kazumoto, Tomoko

WEKO 460730

Kazumoto, Tomoko

Search repository
Kodaira, Takeshi

× Kodaira, Takeshi

WEKO 460731

Kodaira, Takeshi

Search repository
Shikama, Naoto

× Shikama, Naoto

WEKO 460732

Shikama, Naoto

Search repository
Kenjo, Masahiro

× Kenjo, Masahiro

WEKO 460733

Kenjo, Masahiro

Search repository
Tokumaru, Sunao

× Tokumaru, Sunao

WEKO 460734

Tokumaru, Sunao

Search repository
Yamauchi, Chikako

× Yamauchi, Chikako

WEKO 460735

Yamauchi, Chikako

Search repository
Suzuki, Osamu

× Suzuki, Osamu

WEKO 460736

Suzuki, Osamu

Search repository
Sakurai, Hideyuki

× Sakurai, Hideyuki

WEKO 460737

Sakurai, Hideyuki

Search repository
Numasaki, Hodaka

× Numasaki, Hodaka

WEKO 460738

Numasaki, Hodaka

Search repository
Teshima, Teruki

× Teshima, Teruki

WEKO 460739

Teshima, Teruki

Search repository
Oguchi, Masahiko

× Oguchi, Masahiko

WEKO 460740

Oguchi, Masahiko

Search repository
Kagami, Yoshikazu

× Kagami, Yoshikazu

WEKO 460741

Kagami, Yoshikazu

Search repository
Nakano, Takashi

× Nakano, Takashi

WEKO 460742

Nakano, Takashi

Search repository
Hiraoka, Masahiro

× Hiraoka, Masahiro

WEKO 460743

Hiraoka, Masahiro

Search repository
Mitsuhashi, Norio

× Mitsuhashi, Norio

WEKO 460744

Mitsuhashi, Norio

Search repository
加藤 眞吾

× 加藤 眞吾

WEKO 460745

en 加藤 眞吾

Search repository
古平 毅

× 古平 毅

WEKO 460746

en 古平 毅

Search repository
手島 昭樹

× 手島 昭樹

WEKO 460747

en 手島 昭樹

Search repository
小口 正彦

× 小口 正彦

WEKO 460748

en 小口 正彦

Search repository
抄録
内容記述タイプ Abstract
内容記述 To determine the efficacy of a definitive radiotherapy protocol using high-dose-rate intracavitary brachytherapy (HDR-ICBT) with a low cumulative dose schedule in nonbulky early-stage cervical cancer patients, we conducted a prospective multi-institutional study.
METHODS AND MATERIALS:
\nEligible patients had squamous cell carcinoma of the intact uterine cervix, Federation of Gynecologic Oncology and Obstetrics (FIGO) stages Ib1, IIa, and IIb, tumor size <40 mm in diameter (assessed by T2-weighted magnetic resonance imaging), and no pelvic/para-aortic lymphadenopathy. The treatment protocol consisted of whole-pelvis external beam radiotherapy (EBRT) of 20 Gy/10 fractions, pelvic EBRT with midline block of 30 Gy/15 fractions, and HDR-ICBT of 24 Gy/4 fractions (at point A). The cumulative biologically effective dose (BED) was 62 Gy(10) (a/b = 10) at point A. The primary endpoint was the 2-year pelvic disease progression-free (PDPF) rate. All patients received a radiotherapy quality assurance review.
RESULTS:
\nBetween September 2004 and July 2007, 60 eligible patients were enrolled. Thirty-six patients were assessed with FIGO stage Ib1; 12 patients with stage IIa; and 12 patients with stage IIb. Median tumor diameter was 28 mm (range, 6-39 mm). Median overall treatment time was 43 days. Median follow-up was 49 months (range, 7-72 months). Seven patients developed recurrences: 3 patients had pelvic recurrences (2 central, 1 nodal), and 4 patients had distant metastases. The 2-year PDPF was 96% (95% confidence interval [CI], 92%-100%). The 2-year disease-free and overall survival rates were 90% (95% CI, 82%-98%) and 95% (95% CI, 89%-100%), respectively. The 2-year late complication rates (according to Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer of Grade &#8805;1) were 18% (95% CI, 8%-28%) for large intestine/rectum, 4% (95% CI, 0%-8%) for small intestine, and 0% for bladder. No Grade &#8805;3 cases were observed for genitourinary/gastrointestinal late complications.
CONCLUSIONS:
\nThese results suggest that definitive radiotherapy using HDR-ICBT with a low cumulative dose schedule (BED, 62 Gy(10) at point A) can provide excellent local control without severe toxicity in nonbulky (<4-cm) early-stage cervical cancer.
書誌情報 International Journal of Radiation Oncology Biology Physics

巻 82, 号 1, p. e49-56, 発行日 2011-04
ISSN
収録物識別子タイプ ISSN
収録物識別子 0360-3016
DOI
識別子タイプ DOI
関連識別子 10.1016/j.ijrobp.2011.01.022
関連サイト
識別子タイプ URI
関連識別子 http://www.redjournal.org/article/S0360-3016%2811%2900153-2/abstract
関連名称 http://www.redjournal.org/article/S0360-3016%2811%2900153-2/abstract
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 23:53:57.702174
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3